How to Build a Risk-Based Control Strategy for Serialization & Track-and-Trace


Published on 17/06/2026

Developing a Risk-Based Control Strategy for Serialization and Track-and-Trace in Pharmaceuticals

The pharmaceutical industry faces increasing challenges in ensuring compliance with serialization and track-and-trace regulations such as the DSCSA in the US and EU FMD. Non-compliance can lead to significant risks including product recalls, financial penalties, and loss of market access. This article will guide professionals in pharmaceutical manufacturing and quality on building an effective risk-based control strategy tailored for serialization and track-and-trace systems.

Through practical troubleshooting techniques, this article breaks down the symptoms associated with serialization issues, probable causes, immediate containment actions, and long-term corrective measures. By the end of this read, you will have actionable insights to enhance your serialization track-and-trace processes and bolster inspection readiness.

Symptoms/Signals on the Floor or in the Lab

In an effective serialization and track-and-trace environment, specific symptoms signal potential failures. Common issues identified may include:

  • Inconsistent serialization data across batches.
  • Frequent aggregation errors during packaging.
  • Serial number reconciliation discrepancies during audits.
  • Failed verification at distribution or retail endpoints.
  • Unexpected increases in product returns from downstream partners.

These symptoms can indicate operational weaknesses or

deficiencies in the serialization track-and-trace process. Recognizing these signals early is crucial to mitigating escalated compliance risks.

Likely Causes

Identifying the root causes of serialization issues involves analyzing five key categories: Materials, Method, Machine, Man, Measurement, and Environment.

Category Example Causes
Materials Non-compliant packaging materials with embedded codes.
Method Inadequate data entry or coding procedures.
Machine Malfunctions or calibrations not verified on serialization equipment.
Man Lack of training among operators handling serialization processes.
Measurement Insufficient verification methods for validating serial numbers.
Environment Improper storage conditions affecting label or code readability.
Pharma Tip:  CAPA Strategy for aggregation failures in Serialization & Track-and-Trace

Prioritizing these potential causes will help you focus on impactful areas for investigation and corrective actions.

Immediate Containment Actions

In the first hour following the identification of serialization issues, rapid containment actions are essential to prevent further complications. Here are important steps:

  1. Isolate affected product batches immediately from the production line and warehouse.
  2. Cease all serialization-related operations until an investigation is conducted.
  3. Notify relevant stakeholders, including quality assurance and production management teams.
  4. Initiate a preliminary documentation log of affected products and discrepancies observed.

These actions allow you to manage the immediate threat of non-compliance while preparing for a thorough investigation.

Investigation Workflow

A systematic investigation is essential to pinpoint the origin of serialization errors. Follow this workflow to gather relevant data:

  1. Collect documentation related to the affected batches, including production records, packaging logs, and any deviation reports.
  2. Interview personnel directly involved in the serialization process to gather firsthand perspectives on potential failures.
  3. Review machine logs for any operational anomalies or alerts during production.
  4. Examine upstream and downstream processes for potential external impacts, including supplier discrepancies.

Once data collection is completed, categorizing the findings will help in identifying patterns and trends indicating the root cause.

Root Cause Tools

To identify the root cause of serialization problems, employ one of the following tools based on your specific context:

  • 5-Why Analysis: Suited for pinpointing individual causes of straightforward issues by repeatedly asking “why?”
  • Fishbone Diagram: Useful for visualizing multifactorial reasons across the five categories, helping teams brainstorm and categorize root causes.
  • Fault Tree Analysis: Appropriate for complex situations where a defined problem can be dissected into its various contributing factors.

Choosing the right tool depends on the complexity of the issue and the resources available for thorough analysis.

CAPA Strategy

Implementing a robust CAPA (Corrective and Preventive Action) strategy is crucial for resolving serialization issues and preventing recurrence:

  1. Correction: Address immediate issues, such as re-training operators or recalibrating machinery.
  2. Corrective Action: Develop and implement long-term solutions based on root cause analysis, such as revising procedures or addressing material specifications.
  3. Preventive Action: Introduce regular audits, training sessions, and trend monitoring for serialization processes to preempt issues.
Pharma Tip:  How to Improve Right-First-Time Performance in Serialization & Track-and-Trace

Each level of the CAPA strategy corresponds directly to the issues found, ensuring that actions taken are proportionate and effective.

Related Reads

Control Strategy & Monitoring

To sustain improvements in serialization and track-and-trace, a detailed control strategy should integrate continuous monitoring protocols:

  • Statistical Process Control (SPC): Use SPC methodologies to analyze serialization data trends over time.
  • Regular Sampling: Implement periodic sampling and verification of serialized data from production and distribution.
  • Automated Alerts: Set up automated notifications for data discrepancies detected in serialization records.

Establishing an ongoing control strategy fosters a proactive culture of quality assurance within serialization processes.

Validation / Re-qualification / Change Control Impact

After any corrective actions, a validation or re-qualification process must be undertaken to ensure compliance with serialization standards:

  • Validate new procedures to ensure that serialization operates effectively and meets regulatory compliance.
  • Re-qualify equipment that has undergone recalibration or significant modifications related to serialization.
  • Ensure robust change control protocols are followed for all modifications impacting serialization processes.

This formal validation/re-qualification procedure not only guarantees compliance but also reinforces quality by confirming that all systems function as intended.

Inspection Readiness: Evidence to Show

When preparing for regulatory inspections, it is vital to have comprehensive records documenting compliance with serialization regulations:

  • Records: Maintain complete documentation of serialization processes, including batch records and equipment calibration logs.
  • Logs: Keep up-to-date logs capturing any issues, deviations, or corrective actions taken related to serialization.
  • Batch Documents: Ensure all batch production and packaging records reflect accurate serialized data and verification actions.
  • Deviations: Document all deviations found, actions taken, and how they were resolved to corroborate a thorough quality culture.
Pharma Tip:  Regulatory Expectations for Serialization & Track-and-Trace: What QA Must Verify

{Your regulatory authority’s name}, such as the FDA, stresses the importance of maintaining thorough documentation for inspection readiness.

FAQs

What is serialization in pharmaceuticals?

Serialization is the process of assigning a unique serial number to each saleable unit of a product, enabling traceability throughout the supply chain.

Why is track-and-trace important?

Track-and-trace systems are vital for ensuring product integrity, combating counterfeiting, and maintaining compliance with regulations in the pharmaceutical industry.

What are aggregation errors?

Aggregation errors occur when there are discrepancies between how individual serialized units are packed together and what is recorded in the system.

How does DSCSA impact serialization efforts?

The Drug Supply Chain Security Act (DSCSA) mandates compliance with serialization and track-and-trace practices to enhance the security of the pharmaceutical supply chain.

What are the consequences of failing serialization compliance?

Non-compliance may lead to product recalls, financial penalties, loss of market access, and damage to reputation in the industry.

How often should training for serialization be conducted?

Training should occur regularly, particularly when there are updates to procedures, equipment, or regulations affecting serialization processes.

What role do audits play in serialization compliance?

Audits help identify potential issues, ensure consistency in processes, and verify adherence to regulatory requirements related to serialization.

When should a re-qualification take place?

Re-qualification should take place after significant changes to equipment, processes, or when issues affecting compliance are identified and resolved.

If you find our Articles useful
Add us as preferred source on Google
If you find our Articles useful
Add us as preferred source on Google